Analysis Of Refractive Lens Exchange And Cataract Surgeries: Real World Clinical Outcomes
Published 2024 - 42nd Congress of the ESCRS
Reference: FP21.11 | Type: Free paper | DOI: 10.82333/6t8p-ny54
Authors: Fadi Alfaqawi* 1 , Clare ODonnell 2 , Amir Hamid 3 , Shafiq Rehman 1 , Nabila Jones 1
1Optegra Eye Sciences,Optegra Eye Health Care,Manchester,United Kingdom, 2Optegra Eye Sciences,Optegra Eye Health Care,Manchester,United Kingdom;College of Health and Life Sciences,Aston University,Birmingham,United Kingdom, 3Optegra Eye Sciences,Optegra Eye Health Care,Manchester,United Kingdom;Faculty of Biology, Medicine and Health,University of Manchester,Manchester,United Kingdom
Purpose
To investigate the real-world outcomes and complications associated with premium intraocular lens (IOL) implantation following refractive lens exchange (RLE) and cataract surgeries.
Setting
Optegra Eye Hospitals, UK
Methods
Retrospective analysis of electronic medical records, reviewing consecutive eyes of refractive lens exchange or cataract surgery involving Multifocal IOL (MFIOL), Extended Depth Of Field (EDOF), or enhanced monofocal IOL implants from 2010 to 2023. Distance and near visual acuities, refractive outcomes, post operative complications and additional procedures were analysed.
Results
Among 30,758 eyes studied, 16,922 were included, mean patient age was 68±10 years, 60% female. 4,829 patients underwent immediate sequential bilateral cataract/RLE. Intraocular lens distribution: MFIOL (77%), EDOF/enhanced monofocal (22%), accommodative (1%). Mean follow-up time: 122 ± 99 days (range: 1 to 366 days. For visual outcomes, 94% of eyes achieved ≥20/40 and were within ±1.00D of predicted postoperative refraction. Notably, MFIOL eyes (87%) and EDOF (72%) achieved ≥N8. 5% underwent enhancement procedures, with 0.7% return to theatre rate. YAG laser capsulotomy: 16%, cystoid macular oedema incidence: 0.9%. Three cases of endophthalmitis (0.009%) and 24 cases of retinal detachment (0.07%) were reported.
Conclusions
Our findings highlight the efficacy and safety of multifocal and extended depth of field intraocular lenses, providing valuable insights for clinicians and patients considering these procedures.